If you sell hemp-derived products, your processor is reading the same headlines you are, and it is deciding right now which of its CBD merchants it still wants in December. The federal hemp redefinition passed in November 2025 is about to take effect, and underwriting teams are already pricing it in.
This post covers what the law actually changes, which product lines it hits hardest, and what a processor is likely to ask you before the deadline. This is general information, not legal advice.
What Congress changed, in plain terms
The change rode in on the appropriations package that ended the 2025 government shutdown, signed November 12, 2025, as Public Law 119-37. Section 781 rewrote the federal definition of hemp that the 2018 Farm Bill created.
The old test looked at delta-9 THC: 0.3% or less on a dry-weight basis. That gap let delta-8, THCA flower, and hemp-derived delta-9 edibles reach the market as "hemp." The new definition closes it in three ways:
- Total THC, not just delta-9. The 0.3% dry-weight limit now counts total tetrahydrocannabinols, including THCA.
- A per-container cap on finished products. Final hemp-derived cannabinoid products are limited to 0.4 milligrams per container of combined total THC and other cannabinoids with similar effects, not THC alone.
- No synthesized cannabinoids. Cannabinoids that the plant can't naturally produce, or that are synthesized or manufactured outside the plant, fall outside the definition.
The law also directed FDA to publish lists of naturally occurring cannabinoids and THC-class compounds. Industry trackers reported in September 2026 that those lists still had not been published, which leaves some compliance questions open heading into the deadline.
Industrial hemp grown for fiber, grain, and other non-cannabinoid uses keeps its protected status. The squeeze lands on consumer cannabinoid products.
The dates that matter: November 12 and December 11, 2026
The original law took effect one year after signing, on November 12, 2026. In September 2026, a stopgap funding bill, H.R. 6500, pushed most of the new restrictions back to December 11, 2026.
The delay is partial. Cannabinoids that can't be naturally produced by the cannabis plant still lose hemp status on November 12, 2026, according to legal analyses of the bill. Everything else, including the total THC test and the 0.4 mg per-container cap, moved to December 11.
Bills to delay the change further, repeal it, or replace it with a federal regulatory framework have been introduced. None of that is law today. Planning around a rescue that hasn't passed is how merchants end up with frozen balances in January.
A federal deadline tells you when the law changes. Your processor's risk team decides when your account changes, and that date is usually earlier.
Which CBD product lines the redefinition actually hits
The phrase "hemp THC ban" makes it sound like intoxicating products alone are affected. For many CBD brands, the bigger shock is the per-container math.
Intoxicating hemp products
Delta-8 vapes, THCA flower, and hemp-derived delta-9 gummies are the obvious targets. Under a total THC test and a 0.4 mg per-container cap, most of these products no longer fit the federal hemp definition once the restrictions take effect.
Full-spectrum CBD
This is where wellness brands get caught. Full-spectrum oils are made to contain trace THC. Under the old delta-9 dry-weight test, a full tincture bottle could carry far more than 0.4 mg of THC in total and still be compliant. A per-container cap counts every milligram in the package, so many full-spectrum products that were compliant last year are not compliant under the new definition.
Broad-spectrum and isolate products
Products formulated to contain no detectable THC are in a stronger position, provided your lab results show total THC, including THCA, well under the cap for the whole container. Broad-spectrum labels mean nothing to an underwriter without the COA to back them.
Synthesized or converted cannabinoids
Products containing cannabinoids that cannot naturally be produced by the cannabis plant face the November 12, 2026 exclusion. Naturally occurring cannabinoids synthesized or manufactured outside the plant fall under the other exclusions scheduled for December 11, 2026. A lab-converted product should not automatically be assigned the earlier date: have counsel classify each ingredient and confirm your processor's own acceptance deadline.
How processors are likely to react
Processors and their sponsor banks don't wait for an enforcement action to manage risk. They look at their portfolio, ask which merchants could be selling products that fall outside federal hemp status, and act before the card networks or regulators ask them to.
For a CBD merchant, that can mean a product review request, a demand for updated COAs, a new reserve, or a termination notice timed to the deadline. If you've lived through a surprise freeze before, you know the pattern, and our breakdown of why accounts get frozen explains the mechanism.
The merchants most exposed are the ones whose processor never really understood their catalog. A generic account that approved "wellness products" without a SKU list is the account most likely to close abruptly, because the risk team has no way to tell a compliant isolate brand from a delta-8 shop.
What your underwriting file should show before December
The goal is to make your compliance obvious to a reviewer who has twenty other CBD files on the desk. Expect questions along these lines, and have answers ready:
- A current SKU list. Every product, its cannabinoid profile, milligrams per serving, and milligrams per container.
- Third-party COAs reporting total THC. Results should state total THC including THCA and identify other cannabinoids with similar effects, tied to batch numbers, so the combined per-container figure can be checked.
- A transition plan. Which products are being reformulated, which are being discontinued, and the date they come off your site.
- State-by-state shipping rules. Many states already restrict hemp products more tightly than federal law. Show where you ship and where you don't.
- Clean marketing. No disease claims, no "gets you high" language, and age gates where your products or states require them.
Reformulation changes your risk profile, and that is worth telling your processor directly. A brand that drops full-spectrum lines and moves to isolate-based products is a different merchant than it was in 2025, and the file should say so.
Our team works with CBD sellers on exactly this kind of review. Underwriting built around hemp and CBD product catalogs starts from your SKU list, not from a keyword filter.
Reserves, cash flow, and the sell-down problem
Expect higher scrutiny on processing volume in the weeks before the deadline. A spike in sales of soon-to-be-noncompliant products reads as a merchant liquidating inventory, and that's when processors add reserves or hold funds.
If you plan to sell down existing stock before your cutoff, tell your processor in advance and document which products you're selling and when they stop. Surprise volume is the trigger; explained volume usually isn't. If a reserve does appear, our guide to rolling reserves explains how they're calculated and released.
It also helps to keep a second payment rail. ACH processing won't fix a compliance problem, but it can keep revenue moving for compliant products if card processing is paused for review.
Questions to ask your current processor now
Silence from your processor is not a good sign. It usually means nobody has looked at your file yet, and the first look may come with a deadline attached. Ask these questions while you still have time to act on the answers:
- Is my account under review because of the hemp redefinition? A direct question often gets a direct answer, and it tells you whether a review is already scheduled.
- What documentation do you need from me, and by when? Get the list in writing so you're not guessing which COAs or SKU details matter.
- Which products in my catalog concern you? If the answer is "all of them," your processor doesn't know your catalog, and that is a risk in itself.
- What happens to my reserve or held funds if the account closes? Know the release terms before you need them.
Write down the answers and the date you received them. If your account is later closed, a record showing you asked early and supplied what was requested helps when you apply elsewhere.
If the answers are vague, treat that as information. A processor that can't tell you what it needs in October is unlikely to give you much notice in December.
Also check your terms of service for language about prohibited products and changes in law. Most merchant agreements let the processor terminate when a product's legal status changes, and some let it hold funds for an extended period afterward. Knowing that clause now tells you how much cushion you need.
How this differs from the CBD banking problem you already know
For years, the CBD payment story was about the gap between a legal product and a nervous banking system. Our CBD payment processing guide covers that ground. The 2025 redefinition is a different problem: for some products, the law itself has moved.
That means "we're federally legal" is no longer a blanket answer. You need to show which of your products remain hemp under the new definition, line by line, with lab data. Merchants who can do that are in a stronger position than before, because the products that made CBD look risky are leaving the market.
Get your catalog reviewed before the deadline does it for you
Pull your SKU list and your latest COAs this week. Mark every product as compliant, reformulating, or discontinuing under the total THC test and the 0.4 mg per-container cap, and talk to counsel about anything unclear.
Then make sure your processing account is with a team that will read that list. If you want a CBD processing partner that reviews your products before the deadline, start your application with Karma Card Payments.
Sources and timing
Last reviewed October 5, 2026. Network rules and legal requirements can change; confirm the rules that apply to your account and products.